158 related articles for article (PubMed ID: 21187389)
1. Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.
Villares GJ; Zigler M; Dobroff AS; Wang H; Song R; Melnikova VO; Huang L; Braeuer RR; Bar-Eli M
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):626-31. PubMed ID: 21187389
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target.
Villares GJ; Zigler M; Bar-Eli M
Oncotarget; 2011; 2(1-2):8-17. PubMed ID: 21378407
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43.
Villares GJ; Dobroff AS; Wang H; Zigler M; Melnikova VO; Huang L; Bar-Eli M
Cancer Res; 2009 Aug; 69(16):6730-7. PubMed ID: 19679555
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.
Melnikova VO; Balasubramanian K; Villares GJ; Dobroff AS; Zigler M; Wang H; Petersson F; Price JE; Schroit A; Prieto VG; Hung MC; Bar-Eli M
J Biol Chem; 2009 Oct; 284(42):28845-55. PubMed ID: 19703903
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs).
Beltran AS; Blancafort P
Epigenetics; 2011 Feb; 6(2):224-35. PubMed ID: 20948306
[TBL] [Abstract][Full Text] [Related]
6. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
Kim S; Han J; Kim J; Park C
Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
[TBL] [Abstract][Full Text] [Related]
7. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin.
Zhang M; Maass N; Magit D; Sager R
Cell Growth Differ; 1997 Feb; 8(2):179-86. PubMed ID: 9040939
[TBL] [Abstract][Full Text] [Related]
8. Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.
Villares GJ; Zigler M; Wang H; Melnikova VO; Wu H; Friedman R; Leslie MC; Vivas-Mejia PE; Lopez-Berestein G; Sood AK; Bar-Eli M
Cancer Res; 2008 Nov; 68(21):9078-86. PubMed ID: 18974154
[TBL] [Abstract][Full Text] [Related]
9. Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma.
Tellez C; McCarty M; Ruiz M; Bar-Eli M
J Biol Chem; 2003 Nov; 278(47):46632-42. PubMed ID: 12975361
[TBL] [Abstract][Full Text] [Related]
10. Suppression of breast tumor growth and metastasis by an engineered transcription factor.
Beltran AS; Russo A; Lara H; Fan C; Lizardi PM; Blancafort P
PLoS One; 2011; 6(9):e24595. PubMed ID: 21931769
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor.
Beltran AS; Sun X; Lizardi PM; Blancafort P
Mol Cancer Ther; 2008 May; 7(5):1080-90. PubMed ID: 18483297
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype.
Silini A; Ghilardi C; Ardinghi C; Bernasconi S; Oliva P; Carraro F; Naldini A; Bani MR; Giavazzi R
Clin Exp Metastasis; 2010; 27(1):43-53. PubMed ID: 20084489
[TBL] [Abstract][Full Text] [Related]
13. Decreased immunoreactive maspin expression in intermediate thickness and thick primary melanoma lesions.
Vereecken P; Reynaert S; Lalmand MC; Zouaoui-Boudjeltia K; Heenen M; Van Den Heule B; Petein M
J Int Med Res; 2006; 34(1):52-7. PubMed ID: 16604823
[TBL] [Abstract][Full Text] [Related]
14. Nuclear localization of maspin is essential for its inhibition of tumor growth and metastasis.
Goulet B; Kennette W; Ablack A; Postenka CO; Hague MN; Mymryk JS; Tuck AB; Giguère V; Chambers AF; Lewis JD
Lab Invest; 2011 Aug; 91(8):1181-7. PubMed ID: 21502940
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.
Braeuer RR; Zigler M; Villares GJ; Dobroff AS; Bar-Eli M
Semin Cancer Biol; 2011 Apr; 21(2):83-8. PubMed ID: 21147226
[TBL] [Abstract][Full Text] [Related]
16. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.
Dobroff AS; Wang H; Melnikova VO; Villares GJ; Zigler M; Huang L; Bar-Eli M
J Biol Chem; 2009 Sep; 284(38):26194-206. PubMed ID: 19632997
[TBL] [Abstract][Full Text] [Related]
17. Loss of maspin expression contributes to a more invasive potential in malignant melanoma.
Denk AE; Bettstetter M; Wild PJ; Hoek K; Bataille F; Dietmaier W; Bosserhoff AK
Pigment Cell Res; 2007 Apr; 20(2):112-9. PubMed ID: 17371437
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
Liu Z; Shi HY; Nawaz Z; Zhang M
Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
[TBL] [Abstract][Full Text] [Related]
19. Role and regulation of the thrombin receptor (PAR-1) in human melanoma.
Tellez C; Bar-Eli M
Oncogene; 2003 May; 22(20):3130-7. PubMed ID: 12789289
[TBL] [Abstract][Full Text] [Related]
20. Expression and regulation of tumor suppressor gene maspin in breast cancer.
Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
